FDA:No elevated risk of heart attack or death in patients on Avandia

FDA:No elevated risk of heart attack or death in patients on Avandia

The U.S. Food and Drug Administration today announced it is requiring the removal of certain restrictions on prescribing and use of the diabetes drug Avandia (rosiglitazone) to reflect new... [[ This is a content summary only. Visit my website fo...

Close